Ole-Chr. Rutherford

❤️doc | Researcher, focusing on atrial fibrillation, cardiovascular pharmacology, epidemiology

[Ole-Chr. Rutherford @ocrutherford]

@kardioklick @echo_batman @drjohnm I agree, same in our HFU. Sac/val is rarely used.

[Ole-Chr. Rutherford @ocrutherford]

«The only positive trials with sacubutril/Vallarta’s other than PARADIGM are near worthless BNP-trials». One of the most important voices in cardiology worldwide. Check out the podcast!! @drjohnm

[theheartorg | Medscape @theheartorg]

An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by @drjohnm in this week's podcast. https://t.co/cUAnHLNgXc

[Ole-Chr. Rutherford @ocrutherford]

@echo_batman @drjohnm I think the real question is why did they not compare sac/val against ramipril 10mg/d, ACE inhibitors are still recommended as first choice in the guidelines, not ARBs.

[Dan Atar @dan_atar]

#wondrmedical

[European Society of Cardiology Journals @ESC_Journals]

Emerging role for #SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure https://t.co/P6uWoAcmdi

@ehj_ed @rladeiraslopes #EHJ #ESCYoung

[CGEn @CGEnSeq]

Annabel's Master’s research focuses on discovering the function of a novel Autism (ASD) risk gene. "While the Scherer lab has discovered many ASD risk genes, the one I am studying is unique in that it encodes a long noncoding RNA (lncRNA) instead of a protein." #WomenInScience

[European Society of Cardiology Journals @ESC_Journals]

In a nationwide registry - digoxin: lower mortality/morbidity in #HFrEF with AF, but higher mortality/morbidity in HF without AF https://t.co/SHIebtRJHV

#EHJPharmacotherapy #cardiotwitter @AgewallStefan @GianluSava

[ACASA-TAVI @acasatavi]

360 patients aged 65-80 years old without atrial fibrillation or other indications for anticoagulation will be randomized 1:1 to receive either DOAC monotherapy (intervention) or acetylsalicylic acid (standard-of-care) after successful TAVI

[Ole-Chr. Rutherford @ocrutherford]

From @jaccjournals https://t.co/yzQZHpzh8G I agree with @drjohnm : «any future trial of high bleeding-risk patients should include a half-dose DOAC alone, because if this cocktail worked well with a foreign body in the left atrium, it’s possible it could work even better alone»

[Ole-Chr. Rutherford @ocrutherford]

@vinjar ☝🏼

[Ole-Chr. Rutherford @ocrutherford]

@john_munkhaugen med viktig søkelys!
https://t.co/iNIMmMLtHA

[EHJ Editor-in-Chief @ehj_ed]

Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
https://t.co/WrXFgLCBN3
@ESC_Journals #EHJ #cardiotwitter

[Tonje R. Johannessen @tonjerj]

Excited to present our cost evaluation analysis on the low-risk assessment with the ESC 0/1h algorithm in emergency primary care vs hospital ED at the #ESCCongress2021 on behalf of the OUT-ACS group @dan_atar @sighalvo @john_munkhaugen @TorbWis

[The Washington Post @washingtonpost]

Humans have pushed the climate into ‘unprecedented’ territory, landmark U.N. report finds https://t.co/mK9H4ivPju

[theheartorg | Medscape @theheartorg]

Those at low risk for COVID-19 should be allowed to weigh their vaccine decisions without anyone being tarred as an antivaxxer. https://t.co/qKIwUCkC53 via @drjohnm #AgainstAbsolutism #Myocarditis

[Théo Pezel @PezelT]

🚀New impact factors 2021😱
- EHJ: 29.9
- Circulation: 29.7
- JACC: 24.1
- JACC CVI: 14.8
- Circ CVI: 7.8
- EHJCVI: 6.8
- JCMR: 5,4
- JMRI: 4.8
- European Radiology: 5.3
- Radiology: 11.2
- ACVD: 2.3
- Frontiers CV Medicine: 6.1
- Hypertension: 10.2
📲 https://t.co/qlPGDdIuZf

[Ole-Chr. Rutherford @ocrutherford]

Radiofrequency Versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden: The RACE-AF Randomized Controlled Trial https://t.co/QWuSpKU9MK

[Ole-Chr. Rutherford @ocrutherford]

Thank you @sighalvo

[Sigrun Halvorsen @sighalvo]

Happy to share this New paper from Norwegian registries on Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation https://t.co/WtrZkv4c8h. CONGRATULATIONS to Ole-Christian Rutherford!

[Sigrun Halvorsen @sighalvo]

Happy to share this New paper from Norwegian registries on Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation https://t.co/WtrZkv4c8h. CONGRATULATIONS to Ole-Christian Rutherford!

[Douglas Murray @DouglasKMurray]

https://t.co/OpKO5iCaYk